
7.38BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US74006W2070
CUSIP
74006W108
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
50.61
Dividend Share
-
Dividend Yield
-
Earnings Share
-13.39
Wall Street Target Price
627.59
EPS Estimate Current Year
-15.27
EPS Estimate Next Year
-10.18
EPS Estimate Current Quarter
-3.6785
EPS Estimate Next Quarter
-3.7973
Most Recent Quarter
-
Revenue TTM
7,463,000
Gross Profit TTM
-284,296,000
EBITDA
-357,198,016
Profit Margin
0.00%
Return On Assets TTM
-23.04%
Return On Equity TTM
-35.32%
Revenue Per Share TTM
0.353
Qtly Revenue Growth YOY
1349.10%
Diluted Eps TTM
-13.39
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
953.14
Price Book MRQ
5.2397
Enterprise Value Revenue
1215
Enterprise Value EBITDA
-6
70.54
6.48%891.32
5.82%17.12
2.95%446.83
1.15%635.45
1.07%313.72
0.86%835.00
0.00%149.23
-4.15%149.54
-0.78%303.05
-0.19%